Cited by 172DNA Repair MechanismsBRCA gene mutations in cancerUbiquitin and proteasome pathways

NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control

Open access
Wang, Bin, Hurov, Kristen, Hofmann, Kay, Elledge, Stephen J.·2009·Genes & Development

Abstract

The ability to sense and respond to DNA damage is critical to maintenance of genomic stability and the prevention of cancer. In this study, we employed a genetic screen to identify a gene, NBA1 (new component of the BRCA1 A complex), that is required for resistance to ionizing radiation. The NBA1 protein localizes to sites of DNA damage and is required for G2/M checkpoint control. Proteomic analysis revealed that NBA1 is a component of the BRCA1 A complex, which also contains Brca1/Bard1, Abra1, RAP80, BRCC36, and BRE. NBA1 is required to maintain BRE and Abra1 abundance and for the recruitment of BRCA1 to sites of DNA damage. In depth bioinformatics analysis revealed that the BRCA1 A complex bears striking similarities to the 19S proteasome complex. Furthermore, we show that four members of the BRCA1-A complex possess a polyubiquitin chain-binding capability, thus forming a complex that might facilitate the deubiquitinating activity of the deubiquitination enzyme BRCC36 or the E3 ligase activity of the BRCA1/BARD1 ligase. These findings provide a new perspective from which to view the BRCA1 A complex.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.1770309

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IRIF formation of BRCA1 and Rap80 is diminished in Abraxas-/- MEFs.

    “Consistent with the previous notion that Abraxas plays a critical role in the accumulation of BRCA1 to DNA damage sites and formation of the BRCA1-A complex, the IRIF formation of BRCA1 and Rap80 in Abraxas-/- MEF cells were diminished (Figure S1) (Wang and Elledge, 2007; Wang et al., 2009).”
  • The BRCA1 A complex, containing Abraxas, NBA1, BRE, BRCC36, and Rap80, mediates recruitment of BRCA1 to DNA double-strand breaks for DNA damage checkpoint regulation and efficient DNA repair.

    “The BRCA1 A complex, comprised of Abraxas, and other components, NBA1, BRE, BRCC36, and Rap80, is found to play an important role in mediating the recruitment of BRCA1 to DNA double strand breaks for DNA damage checkpoint regulation and efficient DNA repair.”
  • Deletion of the coiled-coil domain in human Abraxas disrupts binding of Abraxas to BRCC36.

    “Previously it was shown deletion of the coiled-coil domain in human Abraxas (ΔCC) disrupts the binding of Abraxas to BRCC36 (Wang et al., 2009)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, B., Hurov, K., Hofmann, K., & Elledge, S. J.
Affiliations
  • Brigham and Women's Hospital (US)
  • Miltenyi Biotec (Germany) (DE)
Venue
Genes & Development
Published
2009-03-04
Volume
23
Issue
6
Pages
729-739
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2147344015
Cited by
172
References
44
Citations by year
2026: 4 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 10 · 2018: 4 · 2017: 6 · 2016: 19 · 2015: 10 · 2014: 10 · 2013: 14 · 2012: 19
Type
posted content
Language
en
Open access
Licence
other-oa
Locations
  • Genes & Development (publishedVersion, other-oa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Howard Hughes Medical Institute
  • Leukemia and Lymphoma Society
  • National Institutes of Health
  • U.S. Public Health Service (1U19A1067751-01)
  • National Cancer Institute (K01CA116275)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
BRCA1-A complex, BRCA1, DNA damage response, ionizing radiation resistance, G2/M checkpoint, genome stability, 19S proteasome, BRCC36, BRe, RAP80, deubiquitination
MeSH terms
Deubiquitinating Enzymes, Amino Acid Sequence, Carrier Proteins, Cell Cycle, DNA Damage, DNA Repair, Humans, Lasers, Membrane Proteins, Molecular Sequence Data, BRCA1 Protein, Polyubiquitin, Cell Line, Tumor, Proteasome Endopeptidase Complex, Adaptor Proteins, Signal Transducing, Ubiquitination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review